LA JOLLA, Calif., September 2, 2025 – Enlaza Therapeutics, the first covalent biologics platform company, today announced a multi-target drug discovery collaboration with Vertex Pharmaceuticals (Nasdaq: VRTX) to utilize Enlaza’s...
Arthur Klausner will sit on a panel at the 11th Annual Drug Delivery Technologies and Deal Making Conference, sponsored by SRI
News | 09. 26. 2006
